Insider Buy/Sell Details for the Biotechnology Industry — September 2026
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1189)
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
17,500
Price
$89.89
Total Value
$1.57M
Shares Held After
79,762
% of Holdings
18.0%
Shares
556,000
Price
$4.96
Total Value
$2.76M
Shares Held After
3,236,171
% of Holdings
14.7%
Protagonist Therapeutics, Inc (PTGX)
Ali Asif — Chief Financial Officer
Shares
46,034
Price
$141.78
Total Value
$6.53M
Shares Held After
59,003
% of Holdings
43.8%
Protagonist Therapeutics, Inc (PTGX)
Ali Asif — Chief Financial Officer
Shares
12,595
Price
$141.77
Total Value
$1.79M
Shares Held After
105,037
% of Holdings
10.7%
NewAmsterdam Pharma Co N.V. (NAMS)
Kastelein Johannes Jacob Pieter — Director
Shares
50,246
Price
$25.03
Total Value
$1.26M
Shares Held After
69,302
% of Holdings
42.0%
Mineralys Therapeutics, Inc. (MLYS)
Congleton Jon — Director
Shares
75,000
Price
$25.46
Total Value
$1.91M
Shares Held After
528,621
% of Holdings
12.4%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President&Immunovant CEO
Shares
200,000
Price
$36.62
Total Value
$7.32M
Shares Held After
1,599,154
% of Holdings
11.1%
Tectonic Therapeutic, Inc. (TECX)
McNamara Peter — Chief Scientific Officer
Shares
536
Price
$23.04
Total Value
$12.35K
Shares Held After
54,305
% of Holdings
1.0%
PTC THERAPEUTICS, INC. (PTCT)
STEELE GLENN JR MD PHD — Director
Shares
12,000
Price
$65.16
Total Value
$781.92K
Shares Held After
22,500
% of Holdings
34.8%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
1,115
Price
$375.00
Total Value
$418.12K
Shares Held After
0
% of Holdings
100.0%
Alto Neuroscience, Inc. (ANRO)
Smith Nicholas Conrad — PRESIDENT AND CFO
Shares
886
Price
$26.87
Total Value
$23.81K
Shares Held After
24,060
% of Holdings
3.6%
Alto Neuroscience, Inc. (ANRO)
Smith Nicholas Conrad — PRESIDENT AND CFO
Shares
23,170
Price
$25.78
Total Value
$597.29K
Shares Held After
24,946
% of Holdings
48.2%
Lipocine Inc. (LPCN)
Higuchi John W. — Director
Shares
15,970
Price
$2.23
Total Value
$35.61K
Shares Held After
241,365
% of Holdings
6.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$546.23
Total Value
$196.64K
Shares Held After
326,363
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
920
Price
$545.13
Total Value
$501.52K
Shares Held After
326,723
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
840
Price
$544.05
Total Value
$457.00K
Shares Held After
327,643
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$543.25
Total Value
$325.95K
Shares Held After
328,483
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
580
Price
$541.76
Total Value
$314.22K
Shares Held After
329,083
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$540.78
Total Value
$259.57K
Shares Held After
329,663
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$538.65
Total Value
$21.55K
Shares Held After
330,143
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$537.67
Total Value
$107.53K
Shares Held After
330,183
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$536.52
Total Value
$85.84K
Shares Held After
330,383
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$531.11
Total Value
$84.98K
Shares Held After
330,543
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$526.09
Total Value
$42.09K
Shares Held After
330,703
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$524.62
Total Value
$41.97K
Shares Held After
330,783
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$523.36
Total Value
$41.87K
Shares Held After
330,863
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$517.16
Total Value
$41.37K
Shares Held After
330,943
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$514.90
Total Value
$41.19K
Shares Held After
331,023
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$511.37
Total Value
$20.45K
Shares Held After
331,103
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$495.32
Total Value
$19.81K
Shares Held After
331,143
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$487.79
Total Value
$39.02K
Shares Held After
331,183
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$482.36
Total Value
$77.18K
Shares Held After
331,263
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
601
Price
$480.79
Total Value
$288.96K
Shares Held After
331,423
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
359
Price
$479.67
Total Value
$172.20K
Shares Held After
332,024
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
650
Price
$478.47
Total Value
$311.00K
Shares Held After
332,383
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
749
Price
$477.43
Total Value
$357.59K
Shares Held After
333,033
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
161
Price
$476.14
Total Value
$76.66K
Shares Held After
333,782
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
207
Price
$554.70
Total Value
$114.82K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
113
Price
$553.78
Total Value
$62.58K
Shares Held After
324,650
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$552.63
Total Value
$66.32K
Shares Held After
324,763
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$551.50
Total Value
$88.24K
Shares Held After
324,883
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$550.47
Total Value
$220.19K
Shares Held After
325,043
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$549.40
Total Value
$131.86K
Shares Held After
325,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$548.25
Total Value
$153.51K
Shares Held After
325,683
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$547.29
Total Value
$218.92K
Shares Held After
325,963
% of Holdings
0.1%
Rapport Therapeutics, Inc. (RAPP)
Gault Cheryl — Chief Operating Officer
Shares
2,075
Price
$33.76
Total Value
$70.04K
Shares Held After
139,914
% of Holdings
1.5%
Rapport Therapeutics, Inc. (RAPP)
Gault Cheryl — Chief Operating Officer
Shares
7,925
Price
$33.04
Total Value
$261.81K
Shares Held After
141,989
% of Holdings
5.3%
Adlai Nortye Group Ltd. (ANL)
Ji Ping — Director
Shares
5,000
Price
$15.95
Total Value
$79.75K
Shares Held After
121,453
% of Holdings
4.0%
Adlai Nortye Group Ltd. (ANL)
Ji Ping — Director
Shares
5,000
Price
$16.03
Total Value
$80.15K
Shares Held After
126,453
% of Holdings
3.8%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
30,000
Price
$37.38
Total Value
$1.12M
Shares Held After
49,923
% of Holdings
60.1%
Showing 1–50 of 1189 transactions (page 1 of 24)